Report copyright - IPF treatment update › media › ... · 2% 9% 10. INSIPRE cohort (n=438) Chicago cohort (n=148) ... –Nintedanib, a tyrosine kinase inhibitor of the FGF, PDGF and VEGF receptors,
Please pass captcha verification before submit form
Please pass captcha verification before submit form